ClinicalTrials.Veeva

Menu

Incobotulinumtoxin A and Yoga-like Isometric Exercise in Adolescent Idiopathic Lumbar Scoliosis

M

Manhattan Physical Medicine and Rehabilitation, LLP

Status and phase

Enrolling
Phase 2

Conditions

Scoliosis; Lumbar Region
Scoliosis; Adolescence
Scoliosis Idiopathic

Treatments

Behavioral: Placebo
Behavioral: Isometric Yoga-like exercise
Drug: Botulinum toxin type A

Study type

Interventional

Funder types

Other

Identifiers

NCT04922983
Pro00047989

Details and patient eligibility

About

The study uses a yoga-like isometric posture and botulinum injections to reduce the curves in adolescent idiopathic lumbar scoliosis. Three previous studies show that the yoga pose is effective for reversing scoliotic curves; Botulinum toxin has been approved by the FDA for teenagers. However, no studies using the two of them together have been done until this one.

Full description

The randomized control 6-month study employs an isometric yoga-like posture to strengthen the weak side, and one set of botulinum injections to weaken the strong side of adolescent idiopathic lumbar scoliosis between 25 and 60 degrees. It is open to people between 12 and 18 years of age who are willing to do the pose every day for three months.

This is a crossover study: After 3 months, every patient who was placebo will be offered the actual proven yoga pose and botulinum toxin injections. Two additional free X-rays at 3 weeks and 3 months following the botulinum injection will also be available to each placebo patient.

In this way every patient - placebo or not - will receive the full proper treatment within 3 months.

Enrollment

42 estimated patients

Sex

All

Ages

14 to 18 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  1. Fourteen - 18 years of age, 2. Scoliotic curve greater than 25 degrees, less than 45 degrees, 3. Stated willingness to do the yoga and yoga-like poses daily, 4. Written, signed consent by patient and parent/guardian 5. Pre-test Cobb films no less than 3 months old read by independent radiologists.
  • Exclusion Criteria:

    1. Neurological, muscular or neuromuscular disease, (e.gs., cerebral palsy, myopathy, stroke),
    2. Genetic abnormalities that affect limb growth, proportionality or metabolism, (e.gs., mucopolysaccharidoses, Marfan's syndrome, Refsums disease).
    3. Pregnancy and other conditions prohibiting X-rays or minute(s)-long exertion (e.gs., congestive heart failure, great weakness, COPD).
    4. Previous exposure to botulinum neurotoxin Type A. Sexually active female subjects must present a recent negative pregnancy test.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

42 participants in 4 patient groups, including a placebo group

Group I: Placebo isometric measure, no injection
Sham Comparator group
Description:
Group I: no isometric yoga-like exercise, no injection given.
Treatment:
Behavioral: Placebo
Group II Isometric yoga-like exercise, placebo injection given
Placebo Comparator group
Description:
Group II isometric yoga-like exercise, injection of preservative-free normal saline.
Treatment:
Behavioral: Isometric Yoga-like exercise
Group III: True isometric exercise, botulinum injection
Active Comparator group
Description:
Group III: Isometric yoga-like exercise, botulinum injection given
Treatment:
Drug: Botulinum toxin type A
Behavioral: Isometric Yoga-like exercise
Crossover
Active Comparator group
Description:
After the three months, Arm I and Arm II patients will be given botulinum injections, and Group I will be given the proper yoga-like exercise. These two arms will constitute a further comparator with their own performances in the first 3 months of the study.
Treatment:
Drug: Botulinum toxin type A
Behavioral: Isometric Yoga-like exercise

Trial contacts and locations

1

Loading...

Central trial contact

Cara M Cipriano, BA; Loren M Fishman, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems